CJD - lyodura and the risk of exposure during healthcare - FAQs


We would like to reassure all our patients that tight regulations govern all infection control processes at Addenbrooke's, and that we strictly adhere to all current guidelines including those to prevent CJD.

 

What is lyodura and why was it used in neurosurgery?

Lyodura is processed dura mater (dura being the tough outside membrane that covers the brain), which was used between 1981 and 1992 to seal wounds following neurosurgery.


Back to top


Lyodura and CJD

The use of lyodura has been associated with the transmission of the infectious agent of Creutzfeldt-Jakob disease (CJD); however, the risk of CJD infection as a result of the use of lyodura remains extremely low.

 


Back to top


When was lyodura used at Addenbrooke's?

Lyodura was used in neurosurgery at Addenbrooke’s between 1981 and 1992. During this time, lyodura was commonly used by surgeons worldwide and no adverse side effects of lyodura were known.

Lyodura is no longer used in neurosurgery at Addenbrooke’s. Patients who have had neurosurgery at Addenbrooke's since 1992 are not at risk of CJD from this medical reagent.

 


Back to top


I had neurosurgery between 1981 and 1992, who can I contact for advice?

We have set up a helpline for any patients (or their relatives) who have undergone neurosurgery at Addenbrooke's between 1981 and 1992 (when lyodura was in use).

If they have any concerns at all, they can contact this free phone number. They will be able to talk in confidence about their case and receive further information.

Helpline: 0800 389 8625 (open Monday to Friday 0900-1800 hrs)

 

Last updated: 10 October, 2007